Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer

Sponsors and Collaborators 

University of Michigan Cancer Center


Continue Reading

Francis (Frank) Worden, University of Michigan Cancer Center

Contact

Cancer Answer Line: 800-865-1125

Investigator

Francis P Worden, MD

University of Michigan Cancer Center

ClinicalTrials.gov Identifer 

NCT01469546